Jakarta - Delayed Quote IDR

PT Kalbe Farma Tbk. (KLBF.JK)

1,450.00
+10.00
+(0.69%)
At close: May 9 at 4:13:54 PM GMT+7

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 8.85T
Earnings 1.08T

Q4'23

Q2'24

Q4'24

Q1'25

0
2T
4T
6T
8T
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1,410.00
1,629.33 Average
1,450.00 Current
2,200.00 High

Earnings Estimate

Currency in IDR Current Qtr. (Mar 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 111213
Avg. Estimate 22.6119.2475.482.01
Low Estimate 22.6119.2472.777.6
High Estimate 22.6119.2477.4689.11
Year Ago EPS 20.712.4170.1675.4

Revenue Estimate

Currency in IDR Current Qtr. (Mar 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1--514
Avg. Estimate 8.79T--34.62T37.66T
Low Estimate 8.79T--34.17T36.19T
High Estimate 8.79T--35T39.38T
Year Ago Sales ----32.63T34.62T
Sales Growth (year/est) ----6.11%8.78%

Earnings History

Currency in IDR 6/30/2024 12/31/2024 3/31/2025
EPS Est. 16.9616.6222.61
EPS Actual 18.2318.8223.57
Difference 1.272.20.96
Surprise % 7.52%13.24%4.24%

EPS Trend

Currency in IDR Current Qtr. (Mar 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 22.6114.1575.482.01
7 Days Ago 18.6313.5574.8581.73
30 Days Ago 18.6313.5574.3480.95
60 Days Ago 18.6318.6374.4381.31
90 Days Ago 18.8618.6374.5681.24

EPS Revisions

Currency in IDR Current Qtr. (Mar 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ----21
Up Last 30 Days ----42
Down Last 7 Days 11----
Down Last 30 Days 11----

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
KLBF.JK 9.24%55.02%7.47%8.77%
S&P 500 13.06%3.09%8.02%13.74%

Related Tickers

MIRA MIRA Pharmaceuticals, Inc.
1.2200
-2.40%
 
GILD Gilead Sciences, Inc.
96.91
-1.27%
 
AMGN Amgen Inc.
265.86
-2.28%
 
NOVO-B.CO Novo Nordisk A/S
444.30
+3.59%
 
MRK Merck & Co., Inc.
75.97
-2.16%
 
PFE Pfizer Inc.
22.28
-1.15%
 
NVO Novo Nordisk A/S
65.77
+1.42%
 
LLY Eli Lilly and Company
734.57
-2.25%